Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ammonia | HCID 222 | — |
| Reactant | Bromerguride | HCID 71266 | — |
| Reactant | Sodium borohydride | HCID 4311764 | — |
| Solvent | Trifluoroacetic acid | HCID 6422 | — |
| Product | HCID 13374940 | HCID 13374940 | 62.2% |
Reaction Steps
In an ice bath, 280 ml of trifluoroacetic acid is cooled and then successively combined, under inert gas, with 12.5 g of 3-(2-bromo-9,10-didehydro-6-methyl-8α-ergolinyl)-1,1-diethylurea (30 millimoles) and 7 g of sodium borohydride in tablet form. The mixture is stirred under ice cooling for 4 hours and, during this time, 2×3 g of sodium borohydride is added. Then the reaction mixture is poured on about 200 ml. of ice and, under ice cooling, gently neutralized with concentrated aqueous ammonia solution (32%). The mixture is extracted with methylene chloride, and the organic phase is then dried with magnesium sulfate and evaporated. The residue is crystallized from ethyl acetate and diisopropyl ether, thus obtaining 6.35 g of 3-(9,10-didehydro-2,3β-dihydro-6-methyl-8α-ergolinyl)-1,1-diethylurea (62% of theoretical). From the mother liquor, another 1.0 g of compound is additionally crystallized. According to NMR analysis, the compound is solely a 3βH-compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04695635 |
|---|
| Source dataset | uspto-grants-1987_09 |
|---|
| ORD ID | ord-a9ff102363094136b8139cd41ee3ed92 |
|---|
| Source note | uspto-grants-1987_09 |
|---|